The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MED | +29.11% | +70.58% | +11.26% | +43% |
| S&P | +13.95% | +78.35% | +12.25% | +168% |
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. Its product category includes fixation system and technology for upper and lower extremities, cranio-maxillofacial, CMX, and KeriMedical. It operates through the following geographical segments: Europe, Middle East, and Africa; Asia Pacific; Latin America; and North America. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
No news articles found for Medartis Ag.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
